Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02549781
Other study ID # 1308093
Secondary ID 2013-A01352-43
Status Terminated
Phase N/A
First received
Last updated
Start date January 31, 2014
Est. completion date April 30, 2014

Study information

Verified date March 2018
Source Centre Hospitalier Universitaire de Saint Etienne
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In France, the prevalence of problem gambling and risk has been estimated at 1.3%. This disorder, currently considered a behavioral addiction is characterized by a loss of control and an excessive focus on the game. The literature on intervening psychological mechanisms in the development of the game led to think that the size of loss of control, central among players, could be understood as a reduction in control capacity but also as automatic activation behavior game. The task of Go-Nogo, commonly used in cognitive psychology, assesses the automatic and controlled components of behavior. Furthermore, different models of the concept of addiction underline the importance of the environment associated with addiction. However, no study takes into account the interaction between the game environment and the involvement of these mechanisms.


Description:

In this study, patients will realize, on a computer, various exercises (called "Go-Nogo") whose principle is: 2 symbols (for example, a circle and a square) appear in random order on the screen computer. The patient will not press the response button (key on the keyboard) that upon the occurrence of one of the two symbols, in dependence upon the command that it has been given by the psychiatrist, and this as quickly as possible. The patient will successively perform 3 versions of this exercise (with a neutral wallpaper, with neutral/games images or with neutral/games tones).Order of the 3 versions will be determined by randomization.


Recruitment information / eligibility

Status Terminated
Enrollment 12
Est. completion date April 30, 2014
Est. primary completion date April 30, 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - For pathological gambler (JP): active casino players meet the diagnostic criteria for pathological gambling according to DSM-IV-TR - For social player (JS): casino players who score the SOGS is less than or equal to 2, and playing at least once a month in a money game and chance. - For non-gamer witnesses (T): play less than once per month to any type of gambling, except for Lotto and Euromillion where the threshold is increased at least once a week. These two draw games are considered more socially enrolled in a leisure practice without necessarily enroll in gambling. - Right handed - Aged between 18-60 years. - Without psychotropic treatment or treatment with a stable and unchanged for over a month. Exclusion Criteria: - Participants with a problem of visual acuity and / or uncorrected hearing. - Other current addiction (except tobacco, for reasons of feasibility). - Current Psychiatric comorbidity - Treatment psychotropic introduced or changed for less than a month. - Subjects with atrial fibrillation, with a pacemaker and / or receiving antiarrhythmic drugs

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Go-Nogo test
In this study, Gambler performing Go-Nogo test. On a computer, various exercises (called "Go-Nogo") whose principle is: 2 symbols (for example, a circle and a square) appear in random order on the screen computer. The patient will not press the response button (key on the keyboard) that upon the occurrence of one of the two symbols, in dependence upon the command that it has been given by the psychiatrist, and this as quickly as possible. The patient will successively perform 3 versions of this exercise (with a neutral wallpaper, with neutral/games images or with neutral/games tones). Order of the 3 versions will be determined by randomization.

Locations

Country Name City State
France CHU de SAINT-ETIENNE Saint-etienne

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Saint Etienne

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Result Go-Nogo test Difference between the number of errors (control) in Go-Nogo test simple and visual-auditory Go-Nogo (composite measure) day 1
See also
  Status Clinical Trial Phase
Completed NCT02552524 - Effect of rTMS in Pathological Gamblers N/A